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Abstract 
Introduction. Prenatal exposure to antiepileptic drugs (AED) is associated with 
developmental compromises in verbal intelligence and social skills in childhood. Our 
aim was to evaluate whether a multi-feature Mismatch Negativity (MMN) paradigm 
assessing semantic and emotional components of linguistic and emotional 
processing would be useful to detect possible alterations in early auditory 
processing of newborns with prenatal AED exposure. 
Material and methods. Data on AED exposure, pregnancy outcome, 
neuropsychological evaluation of the mothers, information on maternal epilepsy 
type, and a structured neurological examination of the newborn were collected 
prospectively. We compared a cohort of 36 AED exposed and 46 control newborns 
at the age of two weeks by measuring MMN with a multi-feature paradigm with six 
linguistically relevant deviant sounds and three emotionally uttered sounds.  
Results. Frontal responses for the emotionally uttered stimuli Happy differed 
significantly in the exposed newborns compared to the control newborns. In addition, 
responses to sounds with or without emotional component differed in newborns 
exposed to multiple AEDs compared to control newborns or to newborns exposed to 
only one AED.  
Discussion. Our study implies that prenatal antiepileptic drug exposure may alter 
early processing of emotionally and linguistically relevant sound information.  
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1. Introduction  
Approximately 0.3-07% of pregnant women in Western countries have a diagnosis 
of epilepsy. Most of them receive antiepileptic medication during pregnancy [1-3]. 
The adverse effects of prenatal antiepileptic drug (AED) exposure have been 
vigorously studied during the last decades. Prenatal exposure to AEDs is associated 
with both structural and functional teratogenic effects [4-6]. The most prominent 
effects have been observed with valproic acid (VPA) which is associated with 
decreased verbal intelligence [4, 7, 8], and an elevated risk of autism spectrum 
disorders [9]. 
Cortical processing can be measured by event-related potentials (ERPs) extracted 
from the electroencephalogram (EEG) already in neonates. ERP measurement is an 
economical and non-invasive technique that provides repeatable and quantitative 
information with high temporal resolution. Auditory processing has been examined by 
using Mismatch negativity (MMN) response [10] and these responses can be 
detected already during neonatal period and also in preterm newborns [11-15]. 
Altered MMN responses are observed in infants and children suffering from several 
neural and developmental conditions including dyslexia or autism spectrum disorder 
[16-22]. More specific alterations in cortical responses have been observed in 
different age groups. Dyslexic adults seem to have impaired pitch discrimination [19, 
23], whereas autistic children have modified MMN responses for pitch and phoneme-
category changes [17, 18]. Moreover, ERPs measured in term or preterm newborns 
may already have predictive value for the later development [14, 20, 21].  
In addition to phonetic changes, MMN responses to changes in the emotional 
components of the sounds have been investigated. Autistic children and adults are 
shown to have impaired discrimination of emotional speech prosody [24, 25]. Altered 
auditory processing of emotional information has been detected in young people with 
conduct disorder symptoms [26]. Orientation to emotionally salient speech may be 
altered in patients with bipolar disorder and job burnout [27, 28]. Recently a multi-
feature MMN paradigm to compare semantic and emotional components of linguistic 
and emotional processing in newborns has been developed [13, 29].  
Taken together, prior literature suggests that the long-term developmental 
compromises after prenatal exposure to AEDs is mainly observed in areas of verbal 
intelligence and social skills [4, 9, 30, 31]. To test whether early precursors of these 
developmental compromise could also be detected in newborns after fetal exposure, 
we used the recently established multi-feature MMN paradigm that allows combined 
assessment of emotional and linguistic processing in the newborn period.  
 
2. Material and methods  
 
2.1. General aspects 
The study was conducted at the Helsinki University Hospital in collaboration with 
Finnish Institute of Occupational Health and University of Helsinki Cognitive Brain 
Research Unit. The ethics committee of the Helsinki University Hospital has 
approved the study. All mothers signed a written informed consent during pregnancy. 
The study protocol followed the Declaration of Helsinki. Recruitment process was 
prospective and included background information, exposure data, pregnancy 
outcome data, and mothers’ neurocognitive evaluation. The process is represented in 
detail in a previous publication [32]. The examinations were carried out between April 
2010 and May 2014. Examiners were blinded to the exposure status of the 
newborns.  
 
2.1. Cohort 
The original cohort included 56 newborns with prenatal AED exposure and 67 control 
newborns. AEDs used during pregnancies were valproic acid (VPA), carbamazepine 
(CBZ), oxcarbazepine (OXC), levetiracetam (LEV), lamotrigine (LTG), topiramate 
(TPM), and clonazepam (CZP). Due to newborn related issues we were not able to 
extract ERP epochs form five of the exposed and six of the control newborns. In 
addition, we missed ERP data due to lack of reference electrode (eight exposed 
newborns) or due to inadequate trigger data or artefacts (7 exposed and 15 control 
newborns). Therefore, a full data set was obtained from 36 exposed and 46 control 
newborns. Of the exposed newborns, 25 were exposed to only one AED 
(Monotherapy group), and 11 newborns to more than one AED (Polytherapy group). 
Exposure status of the monotherapy group is shown see in Table 1. Polytherapy 
combinations were (number of newborns in the group): LTG + LEV (1), CBZ + LEV 
(3), OXC + LEV (1), OXC + GBP (1), LTG + OXC + CZP (1), LTG + LEV + CZP (3), 
LTG + TPM + CLB (1). In the monotherapy group, mean dosages and mean serum 
concentrations during the first trimester were: OXC 825 mg (27 umol/l), LTG 280 mg 
(7.7 umol/l), VPA 740 mg, (total serum concentration 283 umol/l, free serum 
concentration 24 umol/l), and LEV 825 mg.  
 
Of background variables (Table 2), the exposed newborns had lower mean birth 
weight the unexposed newborns. The difference in Apgar scores was due to one 
outlier, and vanished if we left this outlier out. Mothers of the AED group tended to 
have higher educational level and lower performance IQ level than the mothers of the 
control group. Background information is revealed in detail in Table 2. 
 
Neurological status of the newborns were assessed by Hammersmith Neonatal 
Neurological Examination [33]  at the CA of 41 to 42 weeks. As observed before 
when analysing the entire cohort [32], the exposed newborns of this subcohort had 
slightly lower limb and axial tone than the control newborns. The mean Compound 
Optimality Score Tone for exposed newborns of the subcohort was 5.9 and for 
controls 7.1 (p = 0.003), and the mean Total Optimality Score 23.9 and 25.4 (p = 
0.029). Neurological findings were reported in detail in our previous publication [32].  
 
 
2.2. MMN 
EEG signals were collected by using NicOne EEG amplifier at sampling frequency of 
250 or 500 Hz and EEG caps with 20-32 sintered Ag/AgCl electrodes positioned 
according to the International 10-20 standard. For sleep state assessment, we 
included channels for chin EMG, ECG, eye movements, and respiratory sensors. The 
sleep state of trace alternant or quiet sleep was determined visually by using 
NicoletOne Reader software by consensus agreement (MV and SV) when needed. 
MMN recordings were assessed with the multi-feature mismatch negativity paradigm 
during either trace alternant or quiet sleep. A standard stimulus (pseudo-word /ta-ta/), 
six types of linguistically relevant deviant stimuli (vowel duration, vowel change, 
intensity changes (+/-6dB), frequency changes (+/-25.5Hz) and three types of 
emotionally uttered stimuli (happy, angry, sad) were performed as explained in full 
detail in previous publications from Pakarinen et al [29] and Kostiainen et al [13]. The 
stimuli were presented via a loudspeaker located at a distance of approximately 1 
meter. The MMN data were collected from the frontal (F3, Fz, F4), central (C3, Cz, 
and C4), and occipital (Oz) electrodes. The Oz was used as a reference electrode. 
As the paradigm for emotional stimuli was only introduced after the recruitment had 
already started, the first 18 recordings lacked the emotional stimuli. 
Intervals between 100–200 ms and 300–500 ms were considered descriptive for the 
brain responses and the averaged value of the signal within these latency windows 
was collected. The mean amplitude values from frontal electrodes were averaged 
together as electrode line F and from central electrodes as electrode line C. The 
mean values were calculated for each infant and each stimulus type for both time 
windows. To obtain standard-subtracted mean amplitudes, amplitude of standard 
stimulus was subtracted from the mean value in each electrode lines (F and C). 
Epochs with signal values larger than +/- 150μV at any channel, or response average 
larger than +/- 10 microvolts at an individual electrode, were considered to be 
artefactual. Artefactual epochs were rejected, and individual artefactual ERP 
responses were left out from the averages.  
 
2.3. Statistical analysis 
To compare the ERPs of AED exposed and unexposed newborns, the mean 
standard-subtracted ERP amplitudes of frontal and central signals were computed for 
the given time windows.  
Both latency windows (100–200 ms and 300-500 ms) were tested separately. For 
group comparisons, we used independent-sample t-test (2-tailed) for continuous 
variables, and Chi-square test for independence, or if the expected frequency was 
less than five, Fisher’s Exact test, for categorical variables.  
When evaluating whether gender affected the mean amplitudes, we applied one-way 
analysis of variance (ANOVA), and when evaluating the effect of age and 
conceptional age on the brain responses, we applied the analysis of covariance 
(ANCOVA). In cases with multiple comparisons, we applied Bonferroni correction. 
 
 
3. Results  
 
3.1. AED group 
Standard-subtracted mean amplitudes, both emotionally uttered stimuli and 
linguistically relevant deviant stimuli, in the exposed and unexposed newborns are 
shown in Table 3 and Figure 1. 
 
The mean amplitude of the emotional variant Happy in the late latency window from 
the frontal electrode line was found to significantly differ between the groups: the 
exposed newborns showed positive polarity (2.08 uV, SD +/- 3.03) while the controls 
showed negative polarity (-1.30 uV, SD +/- 4.35 p = 0.04). To evaluate the impact of 
age and conceptional age (CA) on the reaction to the stimulus, we conducted one-
way between-groups analysis of covariance (ANCOVA) by using age and CA of the 
newborn as covariates. Exposure status was the independent variable and standard-
subtracted mean amplitude was the dependent variable. After adjusting for age and 
CA, there were still no significant differences between AED and control groups for 
any other stimuli or latency window than emotional variant Happy in the late latency 
window from the frontal electrode line (p = 0.04).  
 
 
3.2. Polytherapy and Monotherapy groups  
Commented [MV1]: Sampsalta 11_2018 käsite ”frontal 
electrode line” kuulostaa neurofysiologille pahalta.  
toki siinä viiva=line, mutta kun tehdään aivotutkimusta niin 
siinä ei ole viiva vaan signaali. 
Siis ERP/EEG/signal from the frontal electrode/brain 
area/tmv. 
 
Tämä tulee pitkin paperia, ehkä voisi kaikki vaihtaa? 
 
Newborns with exposure to more than just one antiepileptic drug (polytherapy group) 
had significantly more positive standard-subtracted mean amplitudes than control 
newborns in the early latency window for emotional variant Angry in the frontal line 
(Polytherapy group 4.26 uV, SD +/-2.41, Control group 0.29 uV, SD +/-3.45, p = 
0.01). The polytherapy group also differed significantly from the control group with 
regard to early positive frequency deviants in both frontal and in central electrode 
lines (frontal electrodes: Polytherapy group -1.02 uV, SD +/-0.89, Control group 0.83 
uV, SD +/-2.60, p < 0.001, and central electrodes: Polytherapy group -1.12uV, SD +/-
1.97, Control group 0.45 uV, SD +/-2.09, p = 0.03). We observed similar statistically 
significant findings when we compared standard-subtracted mean amplitudes of the 
polytherapy and monotherapy groups with each other though monotherapy group as 
itself did not differ significantly from the control group. 
When different monotherapy groups were compared to each other and to the control 
group, we did not find significant differences in standard-subtracted mean amplitudes 
(ANOVA).  
A summary of the statistically significant findings is outlined in Table 4. 
 
4. Discussion  
Our results suggest that prenatal antiepileptic drug exposure may affect early 
processing of emotionally relevant linguistic information. Earlier studies have shown 
that auditory evoked potentials are linked to language functions, and they may 
specifically predict language impairments [34]. There has been an association 
between MMN amplitudes and performance in cognitive tests [35], and the intensity 
of auditory evoked potentials have been shown to correlate with attention [36]. 
Atypical processing of the emotional sounds has been observed in patients with 
autism spectrum disorders [24] [25]. These together are compatible with the idea that 
the present findings might reflect an early precursor of developmental challenge 
caused by AED exposure.   
Our study is in line with previous studies showing no major adverse effects on verbal 
development in association with prenatal OXC, CBZ, LEV, or LTG exposure [4, 7, 8]. 
Our study was initially motivated by the earlier findings that intrauterine VPA 
exposure leads to later risk of verbal and social compromise [37]. Epilepsy patients 
with VPA medication have shown to have decreased P300 amplitudes when 
compared to epilepsy patients with CBZ medication, epilepsy patients without 
medication, or healthy controls [38]. Delayed and smaller MMN responses (N270) 
have been observed in epilepsy patients compared to the responses of healthy 
controls [38].  
The main limitation of our study was the relatively small number of exposed 
newborns in each monotherapy group, particularly VPA group (Table 1). MMN data 
was further limited due to artefact or incomplete electrode settings, and data from 
emotionally uttered stimuli was limited as the paradigm for emotional stimuli was only 
introduced after the first 18 recordings of all MMN data. Thus, the number of the 
newborns exposed to any particular AED was too few to evaluate the impact of an 
individual medication. We cannot exclude the possibility that individual drugs might 
have, either adverse or protective, effects on neonatal auditory processing. 
There are several strengths in this study. The background information including 
exposure data was collected prospectively. During all measurements and analyses, 
the researchers were blinded for the exposure status of the child. Furthermore, MMN 
recordings were conducted during the same sleeping state (quiet sleep) and during 
limited time range (conceptual age) thus eliminating the effects of sleeping states and 
maturation on the quality of the MMN response [39-42].  
In our cohort, there was a trend toward lower mean performance intelligence quotient 
in women with epilepsy than in women without epilepsy (Table 2) which could be 
explained by lower processing speed of the mothers with epilepsy [43]. However, the 
percentage of the women having either tertiary or secondary education was higher 
among women with epilepsy. Higher educational level might be due to 
neuropsychological evaluation included in neurological follow-up thus enabling earlier 
and/or more intensive educational support, or due higher motivation to show one’s 
capacity despite living a life with a chronic disease. Aspects regarding both strengths 
and limitations regarding enrollment and background data collection are discussed in 
more detail in our previous publication [32]. 
MMN paradigms are applied to several clinical approaches to increase understanding 
of disease mechanisms of many neurodevelopmental, neuropsychiatric, and 
neurological disorders, or to serve as biomarkers for risk of these disorders [44]. In 
particular, MMN responses have been used to explore the relationship between 
auditory processing and developmental disorders. It remains seen whether the 
deviant responses to sad and angry stimuli in frontal lines of the polytherapy group in 
our study (Table 4), have correlation to later susceptibility to depression or anxiety 
disorders. MMN might provide a noninvasive bedside method for detection functional 
neurotoxicity associated with fetal drug exposure, and thus offer the possibility of 
early supportive measures [45, 46].  
 Together with other neuroscience techniques, auditory ERP responses have 
supported the idea of continuity in the development of language starting from the 
early precursors of language in the first year of life to full blown linguistic abilities [47]. 
Fetal AED exposure has shown to interfere with several developmental events in 
rodent brain including apoptosis and myelination [44[48]. These particular 
developmental phenomena are reflected in evoked potentials [49]. Functional toxicity 
of fetal AED exposure seen in previous studies [4] may thus have origin in disturbing 
neonatal developmental “building blocks” [48, 50].  
 
By investigating auditory responses already as early as the neonatal time period, we 
were able to focus on the effects fetal exposure and minimize the effect of imminent 
environmental confounders encountered in long term follow up studies. Subtle drug-
related alterations in auditory processing measured in the newborn period may lead 
to developmental compromises later in life. This remains unanswered in the present 
study, and will require further follow-up of the cohort.  
 
5. Conclusions  
Prenatal exposure to antiepileptic drugs may affect auditory processing of 
emotionally relevant information. This may be detected within the first postnatal 
weeks. The clinical relevance and possible applications of evaluating early auditory 
processing still require further research.  
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Figure Captions 
Figure 1. Standard-subtracted mean amplitudes Frontal lines. 
The waveforms of the standard-subtracted mean amplitudes of the newborns 
exposed to antiepileptic drugs (AED, red line) and control newborns (blue dotted 
line) from Frontal (F) electrode lines. Reactions to each emotional variant and each 
deviant are illustrated in separate figures: Happy, Sad, Angry, Vowel change, Vowel 
duration, Positive Intensity Change, Negative Intensity Change, Positive Frequency 
Change, and Negative Frequency Change.  
 
Figure 2. Standard-subtracted mean amplitudes Central lines. 
The waveforms of the standard-subtracted mean amplitudes of the newborns 
exposed to antiepileptic drugs (AED, red line) and control newborns (blue dotted 
line) from Central (C) electrode lines. Reactions to each emotional variant and each 
deviant are illustrated in separate figures: Happy, Sad, Angry, Vowel change, Vowel 
duration, Positive Intensity Change, Negative Intensity Change, Positive Frequency 
Change, and Negative Frequency Change.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. AED exposure 
 
  
OXC*/CBZ* 
N (%) 
 
 
VPA* 
N (%) 
 
 
LTG* 
N (%) 
 
 
LEV* 
N (%) 
 
TPM* 
N (%) 
 
Polytherapy 
N (%) 
 
All 
N (%) 
 
All enrolled   
 
19 (35) 
 
5 (9) 
 
8 (15) 
 
7 (13) 
 
1 (2) 
 
14 (25) 
 
55^ (100) 
 
ERP data 
available  
 
9 (25) 
  
 
   
5 (14) 
 
 
5 (14) 
 
  
6 (17) 
 
 
0 (0) 
 
 
 11 (31) 
 
 
 
36 (100) 
OXC= Oxcarbazepine, CBZ= Carbamazepine, VPA= Valproic acid, LTG= Lamotrigine, LEV= Levetiracetam, TPM= 
Topiramate. *Monotherapy. ^Exposure status is not available for one newborn  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Background information 
 
 
AED (n=46)  Controls (n=36) Sig. (AED vs. 
Controls^) 
GA* (weeks, mean (range, SD)) 40.2 (37.9-42.3, +/-1.15)) 40.3 (38.4-42.1, +/-1.11) 0.67 
CA** during ERP (weeks, mean) 42.3 (40.4-44.4, +/-0.94) 42.2 (40.0-43.7, +/-0.86) 0.81 
Age during ERP (weeks, mean) 2.1 (0.58-0.40, +/-1.04) 2.0 (0.0-4.85, +/-1.04) 0.65 
Enrollment (GA* weeks, mean) 7.35 (3-24, +/-3.75) 10.00 (5-15, +/-7.07) 0.36 
Educational level of the mother 
(primary/secondary/tertiary) 34%/57%/9%  64%/30%/7%  0.05 
Age of the mother (mean, yrs) 31.5 (24.0-41.0, +/-4.36) 31.7 (21.0-38.0, +/-3.66) 0.82 
Smoking during the third trimester (%) 3% 0% 0.53 
Neuropsychology of the mothers 
        VIQ# (mean)  
PIQ ##(mean) 
Executive problems (no 
problems/slight problems)  
 
111 (69-137, +/-13) 
116 (62-132, +/-13) 
72%/28% 
 
115 (103-133, +/-9) 
123 (102-138, +/-10) 
87%/13% 
 
 
0.25^^ 
0.05^^ 
0.46 
Gender (Male %) 64% 69% 0.58 
Apgar at 1 min (mean) 9.0 (7-10) 8.5 (2-10) 0.02 
Folic acid amount during the 1st 
trimester (mean, mg) 2.9 (0.3-5.0, +/-1.75) 3.3 (0-8.0, +/-2.29) 0.42 
Birth Weight (grams) 3480 (2490-4555, +/-465) 3714 (2808-4800, +/-474) 0.03 
Hemoglobin of the newborn 167 (127-199, +/-19) 166 (127-214, +/-22) 0.93 
*GA = Gestational Age (weeks), **CA =Conceptional Age (weeks), #=Verbal Intelligence Quotient, ## =Performance 
Intelligence Quotient, ^ T-test, Pearson’s Chi-Square test or Fisher’s Exact test, ^^After discarding one outlier 
mother with VIQ 69 and PIQ 62 the p- value for VIQ is 0.42 and for PIQ 0.12 (mean VIQ: AED 112, control 114 and 
mean PIQ: AED 117, control 122) 
 
 
 
 
 
 
 
 
 
Table 3.  Standard-subtracted mean amplitudes of AED exposed and control newborns 
Stimulus 
 
AED/100-200 ms 
uV (min, max, SD) 
Control/100-200 ms 
uV (min, max, SD) 
p* 
 
AED/300-500 ms 
uV (min, max, SD) 
Control/300-500 ms 
uV (min, max, SD) 
p* 
Emotional variants       
Happy /ta-ta:/       
Frontal 0.72 (-5.79, 4.74, 
+/-3.14) 
-0.25 (-11.25, 10.95, 
+/- 4.69) 
0.33 2.08 (-3.93, 8.32, +/-
3.03) 
-0.13 (-14.93, 9.36, 
+/- 4.35) 
0.04 
Central 0.51 (-5.03, 3.67, 
+/- 2.19) 
0.21 (-6.61, 6.88, +/- 
2.97) 
0.65 0.44 (-6.08, 3.80, +/-
2.21) 
-0.24 (-14.89, 6.90, 
+/-3.14) 
0.32 
Sad /ta:-ta:/       
Frontal -0.38 (-7.26, 7.63, 
+/-4.21) 
-0.59 (-8.28, 11.45, 
+/- 4.34) 
0.86 1.57 (-6.35, 12.13, 
+/-4.99) 
1.27 (-11.42, 14.41, 
+/-5.44) 
0.83 
Central 0.46 (-0.39, 7.73, 
+/-2.76) 
0.04 (-6.05, 7.67, +/-
2.63) 
0.57 1.01 (-6.66, 6.18, +/-
3.04) 
0.30 (-11.14, 11.50, 
+/- 4.25) 
0.45 
Angry /ta-ta/       
Frontal -0.25 (-10.05, 7.59, 
+/-4.49) 
-0.29 (-7.02, 6.47, +/- 
3.45) 
0.97 0.48, (-5.16, 4.47, 
+/- 2.77) 
1.28 (-8.55, 21.05, 
+/-5.01) 
0.41 
Central 0.45 (-4.35, 7-08, 
+/-2.89) 
0.15 (-8.16, 11.26, 
3.30) 
0.71 0.39 (-2.43, 7.22, +/-
2.14) 
1.53 (-5.11, 18.57, 
+/-4.07) 
0.14 
Deviants       
Vowel change /ta-to/       
Frontal -0.34 (-4.00, 3.75, 
+/-1.88) 
0.26 (-5.33, 7.69, +/-
2.28) 
0.19 0.03 (-2.83, 3.12, +/-
1.58) 
0.34 (-4.52, 5.91, 
+/- 2.26) 
0.47 
Central -0.24 (-2.82, 3.03, 
+/- 1.17) 
-0.02 (-4.93, 4.90, +/- 
1.88) 
0.53 0.27 (-2.78, 3.98, +/-
1.36) 
-0.02 (-2.34, 3.82, 
+/-1.28) 
0.33 
Vowel duration /ta-ta:/       
Frontal -0.10 (-2.42, 5.82, 
+/-1.71) 
0.12 (-5.36, 7.04, +/-
2,58) 
0.64 0.07 (-290, 3.73, +/-
1.59) 
-0.65 (-5.01, 3.13, 
+/-1.90) 
0.07 
Central -0.05 (-2.62, 3.21, 
+/-1.36) 
-0.02 (-4.50, 6.56, +/-
2.06 
0.94 0.08 (-2.18, 2.80, +/-
1.15) 
-0.36, (-4.28, 3.83, 
+/-1.50) 
0.13 
Frequency (positive) /ta-ta/       
Frontal 0.22 (-3.95, 4.81, 
+/-2.40) 
0.83 (-5.45, 6.21, +/- 
2.60) 
0.27 -0.11 (-5.82, 6.21, 
+/-2.50) 
0.12 (-486, 5.61, +/-
2.30) 
0.67 
Central -0.21 (-4.18, 3.30, 
+/- 1.91) 
0.45 (-5.15, 6.07, +/- 
2.09) 
0.13 0.07 (-2.40, 5.63, +/-
1.72) 
0.07 (-5.54, 4.57, 
+/-2.03) 
1.00 
Frequency (negative) /ta-ta/       
Frontal 0.33 (-5.48, 8.40, 
+/-2.90) 
0.29 (-10.34, 12.20, 
+/- 3.66) 
0.95 -0.18 (-4.96, 7.59, 
+/-2.99) 
0.15 (-5.15, 4.58, 
+/-2.06) 
0.57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Outlines of significant differences in standard-subtracted mean amplitudes  
Central 0.14 (-3.24, 6.115, 
+/-1.94) 
0.44 (-7.10, 9.28, +/- 
2.67 
0.56 -0.23 (-3.93, 8.32, 
+/-3.03) 
0.29 (-3.76, 5.64, 
+/-1.72) 
0.19 
Intensity (positive) /ta-ta/       
Frontal 0.30 (-6.16, 5.58, 
+/-2.62) 
-0.08 (-11.35, 8.09, 
+/- 4.05) 
0.60 -0.16 (-5.94, 5.86, 
+/-3.07) 
-0.01 (-5.40, 8.85, 
+/-2.83) 
0.82 
Central -0.002 (-5.95, 2.50, 
+/-1.91) 
0.11 (-9.27, 8.11, +/- 
3.04) 
0.84 0.13 (-3.10, 4.29, 
+/-1.93) 
0.49, (-4.44, 7.21, 
+/-2.13) 
0.43 
Intensity (negative) /ta-ta/       
Frontal 0.34 (-5.87, 8.79, 
+/-3.59) 
0.73 (-4.00, 10,82, 
+/-3.00) 
0.61 1,21 (-3.84, 6.97, 
+/-2.33) 
0.34 (-7.10, 6.37, 
+/-3.02) 
0.14 
Central -0.46 (-5.14, 3.73, 
+/-2.13) 
0.29 (-3.54, 5.09, +/-
2.06) 
0.12 0.47 (-2.76, 4.20, 
+/-1.56) 
0.09 (-11.09, 5.61, 
+/-2.76) 
0.43 
Comparisons AED vs. Controls Mono vs. Controls Poly vs. Controls Mono vs. Poly 
Stimulus 100-200 ms  
300-500 
ms 
100-200 
ms 
300-500 
ms 
100-200 
ms 
300-500 
ms 
100-200 
ms 
300-500 
ms 
Emotional variants  
Happy /ta-ta:/  
   Frontal # 0.04 # # # # # # 
   Central # # # # 3 # # 0.08 
Sad /ta:-ta:/  
   Frontal # # # # 0.06 # 0.02 # 
   Central # # # # # # # # 
Angry /ta-ta/  
   Frontal # # # # 0.01 # 0.02 # 
   Central # # # # # # 0.06 0.04 
Deviants  
Vowel change /ta-to/  
   Frontal # # # # 0.06 # 0.01 # 
   Central # # # # # # # # 
Vowel duration /ta-ta:/  
   Frontal # 0.07 # # # # # # 
   Central # # # # # # # # 
Frequency (positive) 
/ta-ta/  
   Frontal # # # # <0.001 # 0.005 # 
   Central # # # # 0.03 # 0.06 0.10 
Frequency (negative) 
/ta-ta/  
   Frontal # # # # # # # # 
   Central # # # # # # # # 
Intensity (positive) /ta-
ta/  
   Frontal # # # # # # # # 
   Central # # # # # # # # 
Intensity (negative) /ta-
ta/  
   Frontal # # # # # # # # 
   Central # # 0.06 # # # # # 
P-values (t-test) 0.05 - 0.1 are represented with blue, < 0.05 with red, > 0.1 with #.  
AED = newborns exposed to antiepileptic drugs  
Mono = newborns exposed to one drug 
Poly = newborns exposed to more than one drug 
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